HYBIO PHARMACEUTIC revenue breakdown overview

HYBIO PHARMACEUTIC revenue for the last year amounted to 431.00 M CNY, the most of which — 207.64 M CNY — came from its highest performing source at the moment, Preparation, the year earlier bringing 575.26 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought HYBIO PHARMACEUTIC 319.17 M CNY, and the year before that — 625.06 M CNY.